Literature DB >> 3157065

Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.

M Frenken, A J Kaumann.   

Abstract

Large coronary arteries of the dog were contracted with 5-hydroxytryptamine (5-HT). The 5-HT2-receptor antagonist ketanserin antagonized the 5-HT-induced effects. Unlike Brazenor and Angus (Europ J Pharmacol 81:569-576, 1982) who reported insurmountable antagonism of the effects of 5-HT in dog coronaries, we found that the antagonism by ketanserin can be surmounted, provided the concentrations of 5-HT are high enough. Ketanserin also unmasked a saturable component of the 5-HT-induced contractions. Although ketanserin (0.1-1 mumol/l) depressed the maximal force of the saturable component, it did not change its EC50 (-log mol/l 8.0). We conclude that large coronary arteries of dog are contracted by 5-HT mainly through 5-HT2-receptors and to a smaller extent through receptors different from 5-HT2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157065     DOI: 10.1007/bf00515557

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  Convenient apparatus for recording contractions of isolated heart muscle.

Authors:  J R Blinks
Journal:  J Appl Physiol       Date:  1965-07       Impact factor: 3.531

2.  Mechanism of the hypotensive effect of ketanserin.

Authors:  J R Fozard
Journal:  J Cardiovasc Pharmacol       Date:  1982 Sep-Oct       Impact factor: 3.105

3.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

Authors:  J E Leysen; C J Niemegeers; J M Van Nueten; P M Laduron
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

4.  Actions of serotonin antagonists on dog coronary artery.

Authors:  R M Brazenor; J A Angus
Journal:  Eur J Pharmacol       Date:  1982-07-30       Impact factor: 4.432

5.  Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors.

Authors:  R M Brazenor; J A Angus
Journal:  J Pharmacol Exp Ther       Date:  1981-08       Impact factor: 4.030

6.  Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery.

Authors:  E Müller-Schweinitzer; G Engel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

7.  Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

8.  Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors.

Authors:  A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

9.  A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.

Authors:  A J Kaumann; M Frenken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

  9 in total
  11 in total

1.  Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.

Authors:  S J MacLennan; G R Martin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery.

Authors:  G J Molderings; G Engel; E Roth; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

3.  Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.

Authors:  I Sahin-Erdemli; P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

4.  Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.

Authors:  Y Nishimura
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

5.  Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

6.  5-HT1-like receptors requiring functional cyclo-oxygenase and 5-HT2 receptors independent of cyclo-oxygenase mediate contraction of the human umbilical artery.

Authors:  S J MacLennan; M J Whittle; J C McGrath
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

7.  Sumatriptan contracts large coronary arteries of beagle dogs through 5-HT1-like receptors.

Authors:  A A Parsons; C Stutchbury; P Raval; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

8.  A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.

Authors:  A J Kaumann; M Frenken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

9.  Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.

Authors:  B K Kemp; T M Cocks
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Effects of 5-hydroxytryptamine on human isolated placental chorionic arteries and veins.

Authors:  J Reviriego; J Marín
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.